The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 2 , Pages 489-493, February 2010

Ibuprofen for neuroprotection after cerebral ischemia

Presented at the 16th Annual Meeting of the Asian Society for Cardiovascular and Thoracic Surgery, March 15, 2008, Singapore.

  • Yusuke Iwata, MD

      Affiliations

    • Children's National Heart Institute, Children's National Medical Center, Washington, DC
  • ,
  • Olivier Nicole, PhD

      Affiliations

    • UMR-CNRS 6185, Université Caen, Caen, France
  • ,
  • David Zurakowski, PhD

      Affiliations

    • Children's National Heart Institute, Children's National Medical Center, Washington, DC
  • ,
  • Toru Okamura, MD

      Affiliations

    • Children's National Heart Institute, Children's National Medical Center, Washington, DC
  • ,
  • Richard A. Jonas, MD

      Affiliations

    • Children's National Heart Institute, Children's National Medical Center, Washington, DC
    • Corresponding Author InformationAddress for reprints: Richard A. Jonas, MD, Children's National Heart Institute, Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC 20010.

Received 21 July 2008; received in revised form 23 April 2009; accepted 18 May 2009. published online 26 October 2009.

Objective

Ibuprofen has been shown to reduce cerebral ischemic injury, such as may occur after deep hypothermic circulatory arrest. We investigated whether ibuprofen has direct protective effects against excitotoxic neuronal injury, as may be seen after cerebral ischemia, by using a cell culture model.

Methods

Mixed cortical cultures containing neuronal and glial cells were prepared from fetal mice at 13 to 15 days gestation, plated on a layer of confluent astrocytes from 1- to 3-day-old postnatal pups. Near-pure neuronal cultures containing less than 5% astrocytes were obtained from mice of the same gestational stage. Slowly triggered excitotoxic injury was induced at 37°C by 24-hour exposure to 12.5 μmol/L N-methyl-D-aspartate or 50 μmol/L kainate. Neuronal death was quantified by release of lactate dehydrogenase from damaged cells. Data were analyzed using 1-way analysis of variance with Tukey post hoc multiple comparisons.

Results

In mixed cultures, ibuprofen concentrations of 25 μg/mL, 50 μg/mL, and 100 μg/mL all significantly reduced N-methyl-D-aspartate–induced neuronal cell death from 74.5% to 56.1%, 38.7%, and 12.3%, respectively, revealing a strong dose response (P < .001). In near-pure cultures, ibuprofen at a concentration of 25 μg/mL failed to protect neurons, indicating that the neuroprotective effects of ibuprofen require interaction with glial cells. Furthermore, ibuprofen at 100 μg/mL was not protective against neuronal cell death induced by kainate exitotoxicity in near-pure culture but was effective in mixed cultures.

Conclusion

Ibuprofen provides neuroprotection through glial cells against excitotoxic neuronal injury caused by glutamatergic excitotoxicity after cerebral ischemia as demonstrated by reduced neuronal cell death in mixed cell cultures. Further studies are needed to evaluate the potential of ibuprofen to reduce neurologic injury in patients experiencing an hypoxic/ischemic insult.

CTSNet classification: 25

Abbreviations and Acronyms: DIV, days in vitro, LDH, lactate dehydrogenase, NMDA, N-methyl-D-aspartate

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Disclosures: None.

 Supported by National Institutes of Health R01HL060922.

PII: S0022-5223(09)01152-0

doi:10.1016/j.jtcvs.2009.05.049

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 2 , Pages 489-493, February 2010